SUPERNUS PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Supernus Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
Supernus Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $6.45M, a 75.1% decline year-over-year.
Supernus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $32K, a 99.8% decline from 2021.
Supernus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $19.8M, a 52.6% decline from 2020.
Supernus Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $41.7M, a 21.1% increase from 2019.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$32K	-$19.7M	-99.8%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-09
2021	$19.8M	-$21.9M	-52.6%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-09
2020	$41.7M	+$7.27M	+21.1%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-09
2019	$34.4M	+$5.25M	+18%	Jan 1, 2019	Dec 31, 2019	10-K	2022-04-13
2018	$29.2M	-$14.2M	-32.7%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-08
2017	$43.3M	+$84.2M		Jan 1, 2017	Dec 31, 2017	10-K	2020-02-28
2016	-$40.9M	-$41.5M	-6234%	Jan 1, 2016	Dec 31, 2016	10-K	2019-03-01
2015	$666K	+$36K	+5.71%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-01
2014	$630K	+$630K		Jan 1, 2014	Dec 31, 2014	10-K	2017-03-16
2013	$0	$0		Jan 1, 2013	Dec 31, 2013	10-K	2014-03-21
2012	$0	+$16.2M		Jan 1, 2012	Dec 31, 2012	10-K	2014-03-21
2011	-$16.2M	-$15.8M	-3971%	Jan 1, 2011	Dec 31, 2011	10-K	2014-03-21
2010	-$399K			Jan 1, 2010	Dec 31, 2010	10-K	2013-03-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.